| Peter Thomas Curtin, MD | |
|
1500 Duarte Rd, Duarte, CA 91010-3012 | |
| (626) 256-4673 | |
| (626) 408-3911 |
| Full Name | Peter Thomas Curtin |
|---|---|
| Gender | Male |
| Speciality | Hematology/oncology |
| Experience | 45 Years |
| Location | 1500 Duarte Rd, Duarte, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316953862 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | G48635 (California) | Secondary |
| 207RH0000X | Internal Medicine - Hematology | G48635 (California) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| City Of Hope Medical Foundation | 3779751656 | 686 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops targeted anticancer therapeutics, today reported encouraging clinical data with its IMGN901 product candidate in the treatment of relapsed and relapsed/refractory multiple myeloma (MM), including prolonged benefit in patients whose disease had progressed on multiple prior treatment regimens.
Curtis Wray, M.D., an assistant professor of surgery at The University of Texas Health Science Center at Houston (UTHealth) Medical School, has been awarded a grant from the American Cancer Society to find ways to improve the care and quality of life for people with liver cancer. Liver cancer is the sixth most common type of cancer in the world and about 750,000 new cases were diagnosed in 2008.
BioCryst Pharmaceuticals has announced that investigators at St. Jude Children's Research Hospital, Memphis, TN, reported favorable results evaluating peramivir treatment in an animal model of influenza using a highly virulent strain of H5N1 virus (an avian influenza strain that had caused fatal human infection in Viet Nam).
Wound Management Technologies, Inc., a leader in advanced wound care solutions, today announced a major distribution deal with Marketing Media Enterprises, LLC (MME), an Orlando Florida medical products distributor serving the direct-to-consumer and military market.
› Verified 2 days ago
| Entity Name | Regents Of The University Of California |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376646869 PECOS PAC ID: 3577476761 Enrollment ID: O20031112000695 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops targeted anticancer therapeutics, today reported encouraging clinical data with its IMGN901 product candidate in the treatment of relapsed and relapsed/refractory multiple myeloma (MM), including prolonged benefit in patients whose disease had progressed on multiple prior treatment regimens.
Curtis Wray, M.D., an assistant professor of surgery at The University of Texas Health Science Center at Houston (UTHealth) Medical School, has been awarded a grant from the American Cancer Society to find ways to improve the care and quality of life for people with liver cancer. Liver cancer is the sixth most common type of cancer in the world and about 750,000 new cases were diagnosed in 2008.
BioCryst Pharmaceuticals has announced that investigators at St. Jude Children's Research Hospital, Memphis, TN, reported favorable results evaluating peramivir treatment in an animal model of influenza using a highly virulent strain of H5N1 virus (an avian influenza strain that had caused fatal human infection in Viet Nam).
Wound Management Technologies, Inc., a leader in advanced wound care solutions, today announced a major distribution deal with Marketing Media Enterprises, LLC (MME), an Orlando Florida medical products distributor serving the direct-to-consumer and military market.
› Verified 2 days ago
| Entity Name | Eisenhower Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013981554 PECOS PAC ID: 5890689657 Enrollment ID: O20100506000102 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops targeted anticancer therapeutics, today reported encouraging clinical data with its IMGN901 product candidate in the treatment of relapsed and relapsed/refractory multiple myeloma (MM), including prolonged benefit in patients whose disease had progressed on multiple prior treatment regimens.
Curtis Wray, M.D., an assistant professor of surgery at The University of Texas Health Science Center at Houston (UTHealth) Medical School, has been awarded a grant from the American Cancer Society to find ways to improve the care and quality of life for people with liver cancer. Liver cancer is the sixth most common type of cancer in the world and about 750,000 new cases were diagnosed in 2008.
BioCryst Pharmaceuticals has announced that investigators at St. Jude Children's Research Hospital, Memphis, TN, reported favorable results evaluating peramivir treatment in an animal model of influenza using a highly virulent strain of H5N1 virus (an avian influenza strain that had caused fatal human infection in Viet Nam).
Wound Management Technologies, Inc., a leader in advanced wound care solutions, today announced a major distribution deal with Marketing Media Enterprises, LLC (MME), an Orlando Florida medical products distributor serving the direct-to-consumer and military market.
› Verified 2 days ago
| Entity Name | City Of Hope Medical Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871886366 PECOS PAC ID: 3779751656 Enrollment ID: O20110720000244 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops targeted anticancer therapeutics, today reported encouraging clinical data with its IMGN901 product candidate in the treatment of relapsed and relapsed/refractory multiple myeloma (MM), including prolonged benefit in patients whose disease had progressed on multiple prior treatment regimens.
Curtis Wray, M.D., an assistant professor of surgery at The University of Texas Health Science Center at Houston (UTHealth) Medical School, has been awarded a grant from the American Cancer Society to find ways to improve the care and quality of life for people with liver cancer. Liver cancer is the sixth most common type of cancer in the world and about 750,000 new cases were diagnosed in 2008.
BioCryst Pharmaceuticals has announced that investigators at St. Jude Children's Research Hospital, Memphis, TN, reported favorable results evaluating peramivir treatment in an animal model of influenza using a highly virulent strain of H5N1 virus (an avian influenza strain that had caused fatal human infection in Viet Nam).
Wound Management Technologies, Inc., a leader in advanced wound care solutions, today announced a major distribution deal with Marketing Media Enterprises, LLC (MME), an Orlando Florida medical products distributor serving the direct-to-consumer and military market.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Peter Thomas Curtin, MD Po Box 512185, Los Angeles, CA 90051-0185 Ph: () - | Peter Thomas Curtin, MD 1500 Duarte Rd, Duarte, CA 91010-3012 Ph: (626) 256-4673 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops targeted anticancer therapeutics, today reported encouraging clinical data with its IMGN901 product candidate in the treatment of relapsed and relapsed/refractory multiple myeloma (MM), including prolonged benefit in patients whose disease had progressed on multiple prior treatment regimens.
Curtis Wray, M.D., an assistant professor of surgery at The University of Texas Health Science Center at Houston (UTHealth) Medical School, has been awarded a grant from the American Cancer Society to find ways to improve the care and quality of life for people with liver cancer. Liver cancer is the sixth most common type of cancer in the world and about 750,000 new cases were diagnosed in 2008.
BioCryst Pharmaceuticals has announced that investigators at St. Jude Children's Research Hospital, Memphis, TN, reported favorable results evaluating peramivir treatment in an animal model of influenza using a highly virulent strain of H5N1 virus (an avian influenza strain that had caused fatal human infection in Viet Nam).
Wound Management Technologies, Inc., a leader in advanced wound care solutions, today announced a major distribution deal with Marketing Media Enterprises, LLC (MME), an Orlando Florida medical products distributor serving the direct-to-consumer and military market.
› Verified 2 days ago
Sasan Fazeli, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1500 Duarte Rd, Duarte, CA 91010 Phone: 626-256-4673 Fax: 626-408-3911 | |
Mr. Yun Yen, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1500 E Duarte Rd, Duarte, CA 91010 Phone: 626-359-8111 | |
Dr. Randy Allison Taplitz, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1500 Duarte Rd, Duarte, CA 91010 Phone: 626-256-4673 | |
Dr. Liying Cai, M.D., PH.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1500 Duarte Rd, Duarte, CA 91010 Phone: 626-256-4673 | |
Peter Poon-hang Lee, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 1500 Duarte Rd, Duarte, CA 91010 Phone: 626-359-8111 | |
Dr. Sharonlin Bhardwaj, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 1500 Duarte Rd, Duarte, CA 91010 Phone: 626-256-4673 | |
Dr. Martin Valera Consunji, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 1500 Duarte Rd, Duarte, CA 91010 Phone: 626-256-4673 |